Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bio-Rad Laboratories

236.34
-4.0900-1.70%
Post-market: 236.340.00000.00%19:44 EDT
Volume:697.42K
Turnover:166.80M
Market Cap:6.62B
PE:-3.62
High:255.00
Open:250.00
Low:235.56
Close:240.43
Loading ...

BIO-key International Full Year 2024 Earnings: US$2.10 loss per share (vs US$15.21 loss in FY 2023)

Simply Wall St.
·
29 Mar

Bio-Rad Laboratories (BIO) Receives a Hold from Jefferies

TIPRANKS
·
28 Mar

Q4 2024 BIO-Key International Inc Earnings Call

Thomson Reuters StreetEvents
·
28 Mar

BIO-key International Inc (BKYI) Q4 2024 Earnings Call Highlights: Strategic Shifts and ...

GuruFocus.com
·
28 Mar

BIO-key Intl Q4 2024 GAAP EPS $(0.53) Vs $(3.99) YoY, Sales $1.462M Miss $2.290M Estimate

Benzinga
·
27 Mar

BIO-key Intl Q4 EPS $(0.53) Misses $(0.35) Estimate, Sales $1.46M Miss $2.29M Estimate

Benzinga
·
27 Mar

BIO-key Trims 2024 Net Loss 49% to $4.3M, Reflecting Higher Gross Margin and Lower Operating Costs, Offsetting 11% Revenue Decrease Due to Business Transition; Hosts Investor Call Today at 10am ET

GlobeNewswire
·
27 Mar

BIO-key Completes Initial Biometric-Based Identity and Access Management Deployment for New International Defense Agency Customer in Record Time

GlobeNewswire
·
26 Mar

DeFi Sector Token Rebounds, BIO Surges Over 16% in 24 Hours

Blockbeats
·
25 Mar

Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts

GlobeNewswire
·
25 Mar

Identity, Access Management & Biometric Solutions Provider BIO-key International Hosts Q4 Investor Call Thursday, March 27th at 10am ET

GlobeNewswire
·
20 Mar

Alger Russell Innovation Index Updates for First Quarter 2025

PR Newswire
·
18 Mar

Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome

GlobeNewswire
·
17 Mar

BIO-key Partners with California Ed Tech JPA to Make its Identity and Access Management Solutions Available to 195 Member Institutions Serving Over 2.6M Students

GlobeNewswire
·
13 Mar

Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring 2025

GlobeNewswire
·
13 Mar

Bio-Rad Laboratories, Inc. (NYSE:BIO) is a favorite amongst institutional investors who own 60%

Simply Wall St.
·
08 Mar

Biophytis to Participate in BIO-Europe Spring Conference to Discuss Drug Development

TIPRANKS
·
06 Mar

Is Bio-Rad Laboratories, Inc. (BIO) the Best Medical Technology Stock to Buy According to Analysts?

Insider Monkey
·
05 Mar

Genprex to Participate at BIO Europe Spring 2025

PR Newswire
·
04 Mar

FACTBOX-US companies announce layoffs to cut costs

Reuters
·
03 Mar